🇺🇸 Golytely (polyethylene glycol) in United States

18 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 18

Most-reported reactions

1. Aortic Valve Sclerosis — 2 reports (11.11%)
2. Dilatation Ventricular — 2 reports (11.11%)
3. Hepatic Steatosis — 2 reports (11.11%)
4. Hypotension — 2 reports (11.11%)
5. Hypovolaemia — 2 reports (11.11%)
6. Irritable Bowel Syndrome — 2 reports (11.11%)
7. Left Atrial Dilatation — 2 reports (11.11%)
8. Renal Failure Acute — 2 reports (11.11%)
9. Aortic Valve Incompetence — 1 report (5.56%)
10. Cardiac Failure Congestive — 1 report (5.56%)

Source database →

Frequently asked questions

Is Golytely (polyethylene glycol) approved in United States?

Golytely (polyethylene glycol) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Golytely (polyethylene glycol) in United States?

Brooke Army Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.